Professional Documents
Culture Documents
Jabb Our 2019
Jabb Our 2019
Editorial Decision date: October 12, 2018; online publish-ahead-of-print January 30, 2019.
We read with great interest the systematic review by Sugrue mandible to avoid the depressor labii inferioris muscle.
et al concerning the treatment of platysmal bands with By following this landmark, we did not report any mod-
botulinum toxin.1 In this systematic review, the authors ification of the patient’s smiles and lower lip asymme-
included 3 studies published between January 1985 and tries were avoided. However, the technique described by
December 2017 to assess efficacy, injection techniques, Sugrue et al might result in the chemo-denervation of the
and complications associated with botulinum toxin injec- depressor labii inferioris muscles by botulinum toxin dif-
tion for the treatment of platysma bands. These included fusion. This could modify the patient’s smile and could
studies were not cited in the review, making it difficult create asymmetries in the lower lip. The risk of adding
for the reader to find them. In July 2017 we published a injections medial to the labionasal fold should be recog-
trial in which we evaluated the “Nefertiti lift” technique by nized and explained to the patient prior to injection and
injecting 30 patients with abobotulinumtoxin A;2 however, should not be a systematic part of every “Nefertiti lift.”
this trial was not listed in the references of this systematic Additional studies should be done to evaluate the effect
review. Also, as noted by Matarasso and Matarasso, chang- of injecting the DAO and mentalis muscles in addition to
ing the inclusion criteria to include studies that utilized the “Nefertiti” lift.
“standard photography” would have increased the number Also, the authors stated, “the maximum dose per band
of studies included in this systematic review because we of incobotulinumtoxin A was 20IU and for abobotulinum-
think that including only studies that used the Merz scale toxin A was 5IU.” This is an erroneous statement because
was far too limiting.3 in our study,2 every platysmal band was injected with 2 to
The “Nefertiti lift” technique was described in Figure 2 4 injections of 5 units of abobotulinumtoxin A each with a
of the Sugrue et al article. In this figure, the depressor total dose of 10 to 20 units per band.
anguli oris (DAO) and the mentalis muscles were injected Sugrue et al also reported, “By omitting other senes-
along with the inferior mandibular border and the pla- cence changes in the neck, this scale is limited to patients
tysmal bands. We agree that injecting the DAO and the with isolated platysma bands only.” However, in our trial,2
mentalis muscles could target the signs of lower face we also assessed the “other senescence changes in the
aging, but these injections have never been evaluated neck.” We used 6 different photonumeric scales to eval-
in our original article or in any other article describing uate the jowls, marionette lines, oral commissures, neck
the “Nefertiti lift” technique. By adding the injection of
these 2 muscles to their figure, one might think that the
reported results evaluated the injection of the DAO and From Saint Joseph University, Beirut, Lebanon.
mentalis muscles too. In our article, we evaluated only
Corresponding Author:
the results of the original “Nefertiti” technique described Dr Samer Jabbour, Faculty of Medicine, 1 Damascus Street, Beirut,
by Levy.4 All our injections were posterior to the hypo- Lebanon 1107 2180.
thetical line where the nasolabial fold would cross the E-mail: samermed@gmail.com
2 Aesthetic Surgery Journal